LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-4.79%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$618M
AUM Growth
+$618M
(-12%)
Cap. Flow
-$25.3M
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
29.66%
Holding
157
New
16
Increased
43
Reduced
62
Closed
16
Top Buys
| 1 |
Surgery Partners
SGRY
|
$2.43M |
| 2 |
Zebra Technologies
ZBRA
|
$2.39M |
| 3 |
ResMed
RMD
|
$2.22M |
| 4 |
Pinduoduo
PDD
|
$2.11M |
| 5 |
Copart
CPRT
|
$1.94M |
Top Sells
| 1 |
Royal Caribbean
RCL
|
$13.7M |
| 2 |
Conagra Brands
CAG
|
$5.09M |
| 3 |
Thor Industries
THO
|
$4.76M |
| 4 |
Eli Lilly
LLY
|
$3.3M |
| 5 |
Ameriprise Financial
AMP
|
$2.6M |
Sector Composition
| 1 | Healthcare | 32.79% |
| 2 | Technology | 16.63% |
| 3 | Consumer Discretionary | 15.44% |
| 4 | Financials | 11.23% |
| 5 | Industrials | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $23.1M | 3.73% |
134,709
-477
| -0.4% | -$81.7K |
|
2
UnitedHealth
UNH
$281B
| $21.4M | 3.46% |
42,489
-4,740
| -10% | -$2.39M |
|
3
Microsoft
MSFT
$3.77T
| $19.8M | 3.2% |
62,650
+1,801
| +3% | +$569K |
|
4
Vertex Pharmaceuticals
VRTX
$100B
| $18.4M | 2.97% |
52,856
-4,988
| -9% | -$1.73M |
|
5
Manulife Financial
MFC
$52.2B
| $18.4M | 2.97% |
1,004,270
-2,044
| -0.2% | -$37.4K |
|
6
Thermo Fisher Scientific
TMO
$186B
| $17.9M | 2.89% |
35,348
-2,729
| -7% | -$1.38M |
|
7
IQVIA
IQV
$32.4B
| $17.3M | 2.8% |
87,853
-4,971
| -5% | -$978K |
|
|
8
Eli Lilly
LLY
$657B
| $16M | 2.58% |
29,752
-6,138
| -17% | -$3.3M |
|
9
Service Corp International
SCI
$11.1B
| $15.7M | 2.54% |
275,000
-25,000
| -8% | -$1.43M |
|
10
InMode
INMD
$944M
| $15.5M | 2.5% |
508,057
-52,500
| -9% | -$1.6M |
|
11
Merck
MRK
$210B
| $14.1M | 2.28% |
137,094
-1,311
| -0.9% | -$135K |
|
12
Brunswick
BC
$4.15B
| $13.8M | 2.24% |
175,000
-25,000
| -13% | -$1.98M |
|
|
13
Ameriprise Financial
AMP
$48.5B
| $12.5M | 2.02% |
37,812
-7,890
| -17% | -$2.6M |
|
14
Globe Life
GL
$11.3B
| $11.5M | 1.86% |
105,579
-15,000
| -12% | -$1.63M |
|
15
NVIDIA
NVDA
$4.24T
| $11.5M | 1.86% |
26,383
+3,080
| +13% | +$1.34M |
|
16
Equity Lifestyle Properties
ELS
$11.7B
| $11.3M | 1.83% |
177,232
-25,000
| -12% | -$1.59M |
|
17
Labcorp
LH
$23.1B
| $11.2M | 1.81% |
55,683
-5,000
| -8% | -$1.01M |
|
18
Hologic
HOLX
$14.9B
| $11.2M | 1.81% |
160,851
| – | – |
|
|
19
ResMed
RMD
$40.2B
| $11.1M | 1.8% |
75,254
+15,000
| +25% | +$2.22M |
|
20
Chemed
CHE
$6.67B
| $10.4M | 1.68% |
20,000
-5,000
| -20% | -$2.6M |
|
21
Toll Brothers
TOL
$13.4B
| $10.4M | 1.67% |
140,000
-30,000
| -18% | -$2.22M |
|
22
Amazon
AMZN
$2.44T
| $9.75M | 1.58% |
76,684
+2,979
| +4% | +$379K |
|
|
23
Thor Industries
THO
$5.79B
| $9.51M | 1.54% |
100,000
-50,000
| -33% | -$4.76M |
|
24
Virtus Investment Partners
VRTS
$1.36B
| $9.09M | 1.47% |
45,000
| – | – |
|
25
Evolent Health
EVH
$1.12B
| $8.17M | 1.32% |
300,000
| – | – |
|